BioNanomatrix has named Erik Holmlin as its president, CEO, and director. Holmlin succeeds Edward Erickson, who led the company since December 2009.
Prior to joining BioNanomatrix, Holmlin was president and CEO of GenVault, which merged with Integenx last month. Previously, Holmlin served as chief commercial officer at Exiqon. He was also a founder of GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.
Microarrays Inc. has appointed Andrew Jennings as its president of business development. Prior to joining MI, Jennings led the sales organization for Open Biosystems, now Thermo Fisher Scientific, for five years.